Louisiana State University may have found a cure for obesity while
researching drastic weight loss in cancer patients—known as cachexia. (W0
00/00810). Researchers think cachexia follows changes in hormone metabolism. LSU
researchers found an unusual glycoprotein they dubbed azaftig in the urine of
cancer and HIV patients suffering cachexia. Patients suffering extreme weight
loss from other diseases, sepsis, burns or major surgery didn’t have azaftig in
their urine. The glycoprotein binds to receptors on fat cell membranes causing
fat breakdown, so detecting it gives early warning of weight loss. “Azaftig may
aid fat loss in obese humans,” the patent suggests.
More from New Scientist
Explore the latest news, articles and features
Technology
DeepMind AI gives an extra day of warning ahead of deadly cyclones
News
Technology
Most people prefer AI-written stories – and can’t tell when they are made by humans
News
Mathematics
Why winner of biggest prize in maths has decided to work on AI instead
News
Technology
Could a new approach to AI finally deliver artificial general intelligence?
Features
Popular articles
Trending New Scientist articles